The Evolving Landscape of the Economics of HIV Treatment and Prevention

article has not abstract

Vyšlo v časopise: The Evolving Landscape of the Economics of HIV Treatment and Prevention. PLoS Med 9(2): e32767. doi:10.1371/journal.pmed.1001174
Kategorie: Essay
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001174

Souhrn

article has not abstract

Zdroje

1. UNAIDS 2010 UNAIDS report on the global AIDS epidemic 2010. Available: http://www.unaids.org/globalreport/global_report.htm. Accessed 10 September 2011

2. LomborgBPiotP 27 September 2011 Re-thinking the fight against AIDS. Wall Street Journal Online. Available: http://online.wsj.com/article/SB10001424053111904194604576583071258290228.html?KEYWORDS=HIV. Accessed 27 September 2011

3. FauciAS 2011 AIDS: Let science inform policy. Science 333 13

4. CohenMSChenYQMcCauleyMGambleTHosseinipourMC 2011 Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365 493 505

5. WoodEKerrTMarshallBDLiKZhangR 2009 Longitudinal community plasma HIV-1-RNA concentrations and incidence of HIV-1 among injecting drug users: a prospective cohort study. BMJ 338 b1649

6. KirkGGalaiNAstemborskiJLinasBCelentanoD 2011 Decline in community viral load strongly associated with declining HIV incidence among IDU. Abstract 484. 18th Conference on Retroviruses and Opportunistic Infections; 27 February–2 March; Boston, Massachusetts

7. MontanerJSGLimaVDBarriosRYipBWoodE 2010 Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: A population-based study. Lancet 376 532 539

8. DasMChuPLSantosGMScheerSVittinghoffE 2010 Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE 5 e11068 doi:10.1371/journal.pone.0011068

9. WalenskyRPFreedbergKAWeinsteinMCPaltielAD 2007 Cost-effectiveness of HIV testing and treatment in the United States. Clin Infect Dis 45 S248 S254

10. WalenskyRPPaltielADFreedbergKA 2002 AIDS drug assistance programs: highlighting inequalities in human immunodeficiency virus-infection health care in the United States. Clin Infect Dis 35 606

11. DuffPKippWWildTCRubaaleTOkech-OjonyJ 2010 Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda. J Int AIDS Soc 13 37

12. HornbergerJHolodniyMRobertusKWinnikeMGibsonE 2007 A systematic review of cost-utility analyses in HIV/AIDS: Implications for public policy. Med Decis Making 27 789 821

13. JohnstonKMLevyARLimaVDHoggRSTyndallMW 2010 Expanding access to HAART: a cost-effective approach for treating and preventing HIV. AIDS 24 1929 1935

14. BadriMWilsonDWoodR 2002 Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 359 2059 2064

15. BhagarvaABigombeB 2003 Public policies and the orphans of AIDS in Africa. BMJ 326 1387 1389

16. DixonSMcDonaldSRobertsJ 2002 The impact of HIV and AIDS on Africa's economic development. BMJ 324 232 234

17. WalenskyRPPaltielADLosinaEMorrisBScottAS 2010 Test and Treat DC: forecasting the impact of a comprehensive HIV strategy in Washington, DC. Clin Infect Dis 51 392 400

18. MillerWCRosenbergNERutsteinSEPowersKA 2010 Role of acute and early HIV infection in the sexual transmission of HIV. Curr Opin HIV AIDS 5 277 282

19. VolkowNMontanerJ 2010 Enhanced HIV testing, treatment, and support for HIV-infected substance users. JAMA 303 1423 1424